Page last updated: 2024-08-22

lutetium and Neutropenia

lutetium has been researched along with Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerman, OC; Boers-Sonderen, MJ; Desar, IM; Langenhuijsen, JF; Mulder, SF; Mulders, PF; Muselaers, CH; Oosterwijk, E; Oyen, WJ; Stillebroer, AB; van Herpen, CM; van Oostenbrugge, TJ	1

Trials

1 trial(s) available for lutetium and Neutropenia

Article	Year
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma. European urology, 2016, Volume: 69, Issue:5 Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Carbonic Anhydrase IX; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Lutetium; Neutropenia; Non-Randomized Controlled Trials as Topic; Radioimmunotherapy; Radioisotopes; Retreatment; Thrombocytopenia	2016

Article

Year

Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.

European urology, 2016, Volume: 69, Issue:5

Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Carbonic Anhydrase IX; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Lutetium; Neutropenia; Non-Randomized Controlled Trials as Topic; Radioimmunotherapy; Radioisotopes; Retreatment; Thrombocytopenia

2016